The nursing home population is particularly vulnerable, and that’s why there’s an increased focus on the use of certain medications for these patients.
Multiple state and federal governmental agencies are taking a closer look at the use of psychotropic medications in the nursing home population.
Information suggests that some nursing home patients may be inappropriately given psychotropic medications for sedation and patient management purposes, and now the U.S. Department of Health and Human Services Office of Inspector General, Centers for Medicare & Medicaid Services, and U.S. Senate are intensifying their focus on this critical topic.
Download our new white paper, “Evaluating the Proper Use of Psychotropic Medications in Nursing Homes,” for expert insights into ongoing monitoring of medication use, the history of these prescriptions in nursing homes, and key questions and action items moving forward.